In general, most studies classify HCC into two main types [10], one being the “proliferation class”, poorly differentiated aggressive tumors associated with HBV infection, enriched in TP53 inactivating mutations and with activated signaling pathways like mTOR, RAS-MAP, and MET. Here, TP53 is linked to hepatocellular carcinoma.